Dopa preparation containing levodopa and carbidopa. | | |
Dopamine precursor used to increase CNS dopamine levels in Parkinson's disease. | | |
Neurological disorder characterized by chronic multiple tics. | | |
This dopamine receptor tied is localized in the substantia nigra zona compacta and presynaptically on striatal axons from dopaminergic substantia nigral cells. | | |
Dopamine receptor type probably most important in mediating benefits of dopaminergic anti-Parkinsonian drugs. | | |
Dopamine agonist; ergot derivative. | | |
Pergolide. | | |
Example of an antimuscarinic agent useful in managing Parkinson's disease. | | |
Benztropine mesylate. | | |
Useful in managing the
sensual tremor. | | |
Antiepileptic agent useful in managing essential tremor. | | |
May alleviate acute dyskinesia/dystonia precipitated by initial doses of phenothiazine antipsychotics. | | |